Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

HIGHLIGHTS

• who: Kenichi Harano and colleagues from the Editor:, University of South Alabama have published the research work: Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0204513]. October 12, 2018 of /1371/
• what: Only 10 patients (11%) in this study had BL2-subtype disease. The study demonstrated that the rate of IM+ subtype differs according to TNBC subtype, with the highest percentage of IM+ cases seen among BL1-subtype tumors and no IM+ cases seen among M . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.